Shim Heejung, Chasman Daniel I, Smith Joshua D, Mora Samia, Ridker Paul M, Nickerson Deborah A, Krauss Ronald M, Stephens Matthew
Department of Human Genetics, University of Chicago, Chicago, IL, USA.
Center for Cardiovascular Disease Prevention, Brigham and Womens Hospital and Harvard Medical School, Boston, MA, USA.
PLoS One. 2015 Apr 21;10(4):e0120758. doi: 10.1371/journal.pone.0120758. eCollection 2015.
We conducted a genome-wide association analysis of 7 subfractions of low density lipoproteins (LDLs) and 3 subfractions of intermediate density lipoproteins (IDLs) measured by gradient gel electrophoresis, and their response to statin treatment, in 1868 individuals of European ancestry from the Pharmacogenomics and Risk of Cardiovascular Disease study. Our analyses identified four previously-implicated loci (SORT1, APOE, LPA, and CETP) as containing variants that are very strongly associated with lipoprotein subfractions (log(10)Bayes Factor > 15). Subsequent conditional analyses suggest that three of these (APOE, LPA and CETP) likely harbor multiple independently associated SNPs. Further, while different variants typically showed different characteristic patterns of association with combinations of subfractions, the two SNPs in CETP show strikingly similar patterns--both in our original data and in a replication cohort--consistent with a common underlying molecular mechanism. Notably, the CETP variants are very strongly associated with LDL subfractions, despite showing no association with total LDLs in our study, illustrating the potential value of the more detailed phenotypic measurements. In contrast with these strong subfraction associations, genetic association analysis of subfraction response to statins showed much weaker signals (none exceeding log(10)Bayes Factor of 6). However, two SNPs (in APOE and LPA) previously-reported to be associated with LDL statin response do show some modest evidence for association in our data, and the subfraction response proles at the LPA SNP are consistent with the LPA association, with response likely being due primarily to resistance of Lp(a) particles to statin therapy. An additional important feature of our analysis is that, unlike most previous analyses of multiple related phenotypes, we analyzed the subfractions jointly, rather than one at a time. Comparisons of our multivariate analyses with standard univariate analyses demonstrate that multivariate analyses can substantially increase power to detect associations. Software implementing our multivariate analysis methods is available at http://stephenslab.uchicago.edu/software.html.
我们对来自药物基因组学与心血管疾病风险研究的1868名欧洲血统个体进行了全基因组关联分析,该分析涉及通过梯度凝胶电泳测量的低密度脂蛋白(LDL)的7个亚组分和中间密度脂蛋白(IDL)的3个亚组分,以及它们对他汀类药物治疗的反应。我们的分析确定了四个先前涉及的基因座(SORT1、APOE、LPA和CETP),其包含与脂蛋白亚组分非常强烈相关的变异(对数(10)贝叶斯因子>15)。随后的条件分析表明,其中三个(APOE、LPA和CETP)可能含有多个独立相关的单核苷酸多态性(SNP)。此外,虽然不同的变异通常与亚组分组合呈现不同的特征性关联模式,但CETP中的两个SNP在我们的原始数据和复制队列中均呈现出惊人的相似模式,这与共同的潜在分子机制一致。值得注意的是,尽管在我们的研究中CETP变异与总LDL无关联,但它们与LDL亚组分非常强烈相关,这说明了更详细的表型测量的潜在价值。与这些强烈的亚组分关联形成对比的是,亚组分对他汀类药物反应的遗传关联分析显示出弱得多的信号(均未超过对数(10)贝叶斯因子6)。然而,先前报道与LDL他汀类药物反应相关的两个SNP(在APOE和LPA中)在我们的数据中确实显示出一些适度的关联证据,并且LPA SNP处的亚组分反应谱与LPA关联一致,其反应可能主要归因于Lp(a)颗粒对他汀类药物治疗的抗性。我们分析的另一个重要特征是,与大多数先前对多个相关表型的分析不同,我们对亚组分进行联合分析,而不是一次分析一个。我们的多变量分析与标准单变量分析的比较表明,多变量分析可以大幅提高检测关联的能力。实现我们多变量分析方法的软件可在http://stephenslab.uchicago.edu/software.html获取。